Open Access<p>Fasting blood glucose levels and prognosis in patients with non-small-cell lung cancer: a prospective cohort study in China</p>
Author(s) -
Jing Yang,
GuoChong Chen,
JiaYing Xu,
Chen-Jie Ling,
Na Yu,
Jing Yang,
Daxiong Zeng,
Min-Jing Gu,
Dapeng Li,
Yusong Zhang,
LiQiang Qin
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s210103
Subject(s) - medicine , lung cancer , hazard ratio , confidence interval , proportional hazards model , prospective cohort study , medical record , cohort , confounding , cancer , cohort study
Non-small-cell lung cancer (NSCLC) is the most diagnosed lung cancer and is associated with poor prognosis. This study aimed to analyze whether fasting blood glucose (FBG) levels could provide prognostic information in Chinese patients with NSCLC, using the Suzhou Lung Cancer Survival study.